Power And Sample Size Considerations In A Pre-Maturely Terminated Randomized, Double-Mask, Placebo-Controlled, Dose-Response, Phase 2 Study Of The Safety And Efficacy Of Thymosin Beta 4 For The Treatment Of Persistent Corneal Epithelial Defects Resulting

Power And Sample Size Considerations In A Pre-Maturely Terminated Randomized, Double-Mask, Placebo-Controlled, Dose-Response, Phase 2 Study Of The Safety And Efficacy Of Thymosin Beta 4 For The Treatment Of Persistent Corneal Epithelial Defects Resulting

Bibliographic Details
Main Author: Jeng, Bennie Hau
Language:English
Published: Case Western Reserve University School of Graduate Studies / OhioLINK 2011
Subjects:
Medicine
Persistent epithelial defects
cornea
Thymosin beta 4
Online Access:http://rave.ohiolink.edu/etdc/view?acc_num=case1323456256

Internet

http://rave.ohiolink.edu/etdc/view?acc_num=case1323456256

Similar Items